Entries by

Keep an eye on the Meta-Analysis Project

One Alcor-funded research project that I’m personally especially interested in is the Meta-Analysis Project. This project, led by Advanced Neural Biosciences’ Aschwin de Wolf and Michael Benjamin, gathers a vast amount of data on every one of Alcor’s cryopreservations and analyzes patterns. ANB began the Alcor Meta-Analysis Project in January 2019 with the goal of developing […]

Please donate appreciated cryptocurrency to Strengthen Alcor

In recent years, Alcor has benefited from cryptocurrency donations. In fact, our largest ever research donation of $5,000,000 from Brad Armstrong was in the form of donated cryptocurrency (Stellar). This immediately led to the creation of the Hal Finney Cryonics Research Fund. Although we don’t have a formal survey, it’s clear that Alcor members are […]

Recent media about Alcor and cryonics

On April 26, Alcor welcomed YouTube interviewer David Allen to Alcor. David’s show, Abnormal Voyages, spotlights “the more unique and unusual places that people may not have heard of before”. David’s goal is to be both educational and entertaining. I found him pleasant and fun as an interviewer. The results reflect that. Hopefully, this video […]

A-3024 became Alcor’s 182nd patient in April 2021

A-3024 was a 68-year-old male with inoperable brain cancer who had neuro cryopreservation arrangements. Legal death was declared in Northern California, USA, and the stabilization team arrived seven hours later, four hours after being notified. After stabilization and field neuro cryoprotection, the patient was transported to Alcor for cryogenic cooldown. A full case report is […]

Tell us your favored podcasts if they might be interested in cryonics

As a tax-exempt non-profit organization, an important part of Alcor’s mission is to educate the public about cryonics. The final plank of our Mission Statement is: “Awareness and growth of cryonics by educating the public.” We have done that though one-on-one conversations, media interviews for radio, TV, and documentaries, by giving talks at conferences and […]

Alcor enters its 50th Year

On February 23, Alcor turned 49 years old. If you’re read my recent two-part article in Cryonics on organizational longevity, you’ll know that’s already a relatively impressive run. We will have to keep the organization humming for decades to come but next year’s 50th anniversary offers a good opportunity to celebrate Alcor’s longevity. It might […]

Alcor Members and Patients: Where and How Many?

Curious about the number of Alcor members and patients, where they are, and how many are neuro and who many whole body? You can find the numbers for the end of the previous month on the website here: https://www.alcor.org/library/alcor-membership-statistics/ But that what you find there may not satisfy. Here’s a more complete update, as of […]

Alcor in Imagine Beyond mini-documentary

A new documentary that strongly features Alcor was released on YouTube on December 28. Imagine Beyond: Who Wants to Live Forever? allows us to present some of the case for cryonics, bolstered by good filming and supportive comments from others about life extension. It’s unfortunate that the description uses inappropriate terms such as “forever” and […]

Support our new research initiative: RAPID! (Readiness And Procedure Innovation/Deployment)

In order to advance the science and reputation of cryonics, Alcor plans to conduct ongoing research to develop novel and near-future products related to cryopreservation procedures and protocols. The RAPID team is developing relationships and contracts to procure recently deceased human cadavers, which are not Alcor members or patients, but are already earmarked for medical […]

A-2705 became Alcor’s 181st patient in August 2020

A-2705 was a 67-year-old male with neuro cryopreservation arrangements who used the death with dignity laws in his state to legally terminate his life. His cause of death was kidney failure. He was pronounced legally deceased in August in the state of Washington at 17:17 hrs on T-0 days. A field cryoprotection (FCP) was performed […]